Introduction: When Healthcare Maturity Does Not Predict Recovery

In the aftermath of the COVID-19 pandemic, many MedTech leaders naturally assumed that countries with highly developed healthcare infrastructure, stronger economic positioning, and well-established public health systems would be the fastest to recover lost surgical procedure volumes. By this logic, mature European markets such as Italy would be expected to rebound more quickly than countries in Latin America, where healthcare systems are often perceived as less resourced and more fragmented.

However, procedure-level data tells a very different story.

Using IQVIA’s MedTech Market Monitor, this analysis compares cardiovascular surgical procedure recovery in Italy and Colombia — two countries with similar population sizes but fundamentally different healthcare system structures and market maturity. Contrary to expectations, the data shows that Colombia has returned to positive growth in cardiovascular surgical volumes, while Italy continues to lag behind its pre-pandemic trajectory.

This unexpected divergence highlights a critical lesson for MedTech manufacturers: healthcare sophistication and economic strength alone are poor predictors of post-pandemic recovery. True insight lies in understanding how demographics, capacity constraints, reimbursement models, technology adoption, and patient behaviour interact at a local level.

By examining why Italy and Colombia have followed such different recovery paths, this blog demonstrates the strategic value of granular, country-specific MedTech surgical data — and why tools like IQVIA’s MedTech Market Monitor are essential for informing market access, portfolio strategy, and long-term growth planning.

Cardiovascular Surgical Procedure Recovery: Italy vs. Colombia

Using IQVIA MedTech Market Monitor data, we assessed cardiovascular surgical volumes before the pandemic, during COVID disruption, and in the post-COVID recovery phase.

Pre-COVID Trends: Growth vs. Saturation

• Colombia showed strong year-on-year growth in cardiovascular procedures prior to COVID, reflecting expanding access, increasing adoption of MedTech innovations, and rising procedural capacity.
• Italy, by contrast, demonstrated slower growth consistent with a mature and saturated healthcare market, where procedure volumes had largely stabilised.

These baseline differences are crucial: recovery dynamics cannot be interpreted without understanding where each market started.

COVID Impact: Disruption Was Not Equal

During the pandemic, Italy experienced a dramatic decline in cardiovascular surgical procedures, with volume reductions approximately 4.5 times greater than those seen in Colombia.

This disproportionate impact reflects:

• Greater COVID burden on hospital infrastructure
• Higher reliance on public healthcare delivery
• A patient population at significantly higher clinical risk

Colombia’s decline, while significant, was more moderate — setting the stage for a faster rebound.

Post-COVID Recovery: An Unexpected Divergence

One might expect a well-funded, highly developed healthcare system like Italy’s to rebound more quickly. However, MedTech Market Monitor data reveals the opposite:

• Italy’s cardiovascular surgical volumes remain below pre-COVID growth trajectories, with continued decline relative to historical trends.
• Colombia has returned to positive growth, rapidly recovering and in some cases exceeding pre-pandemic momentum.

This divergence highlights why headline economic strength alone is insufficient for MedTech market forecasting.

Source: IQVIA MedTech Market Monitor

Why Is Italy Rebounding Slower Than Colombia? Key Drivers Explained

1. Demographic and Epidemiologic Structure

Colombia’s younger population presents:

• Lower baseline procedural penetration
• Greater long-term growth potential
• Faster recovery of elective and semi-elective procedures

Despite similar population sizes, Italy’s over-65 population share is more than double Colombia’s — a critical factor shaping procedural recovery.

Source: IQVIA MedTech

2.Healthcare Capacity and System Recovery

Italy’s hospitals faced prolonged post-COVID strain:

• ICU and operating room capacity remained constrained
• Backlogs forced prioritisation of urgent cases over elective surgery
• Resource saturation slowed procedural normalisation

Colombia’s healthcare system, while more fragmented, proved operationally agile:

• A strong private sector rapidly scaled activity post-2021
• Financial incentives accelerated procedural recovery
• Hospitals moved quickly to restore revenue-generating services

3. Economic, Reimbursement, and Policy Effects

In Italy:

• Public healthcare budgets faced tighter controls post-COVID
• Spending shifted toward primary care, prevention, and long-COVID management
• Some surgical volume decline reflects substitution toward non-invasive therapies

In Colombia:

• A volume-driven reimbursement environment encourages procedural growth
• Expanded insurance coverage over the past decade increased access to tertiary care

4. Clinical and Technology Adoption Dynamics

Italy has accelerated adoption of minimally invasive cardiovascular technologies, such as catheter-based interventions, which may reduce open surgical volumes without reducing total treatment rates.

In Colombia, adoption of newer technologies has been slower, meaning:

• Traditional surgical procedures remain a primary treatment pathway
• Growth continues from previously unmet clinical demand

5. Social Equity and Patient Behaviour

Post-COVID behavioural effects continue to shape recovery:

• In Italy, elderly patients show persistent hesitancy toward hospital-based care
• Colombia’s younger population and healthcare-seeking behaviour have normalised more quickly

Why MedTech Surgical Data Matters More Than Ever

These findings underscore a critical reality for MedTech manufacturers: procedure recovery is not uniform, predictable, or purely economic. It is shaped by demographics, policy, capacity, technology, and patient behaviour — all of which vary dramatically by country.

Without granular, longitudinal surgical data, these insights remain invisible.

Key Considerations for MedTech Manufacturers

To navigate post-pandemic markets effectively, MedTech leaders should consider:

• Market prioritisation: Mature markets may recover more slowly than emerging ones despite stronger infrastructure.
• Portfolio alignment: Declines in surgical volume may reflect technology substitution rather than reduced clinical need.
• Market access strategy: Reimbursement incentives and healthcare funding models strongly influence recovery speed.
• Demand forecasting: Demographic structure and patient behaviour must be factored into long-term projections.
• Investment timing: Growth opportunities may be greatest where baseline penetration remains low but recovery is rapid.

Conclusion: Turning Surgical Data into Strategic Advantage

The contrasting recovery paths of Italy and Colombia illustrate why MedTech strategy cannot rely on assumptions or averages. Country-specific surgical data is essential for identifying true growth opportunities, anticipating risks, and aligning innovation with real-world clinical demand.

IQVIA’s MedTech Market Monitor provides the depth, consistency, and historical perspective needed to transform post-pandemic uncertainty into informed, confident decision-making — empowering MedTech manufacturers to shape strategy, optimise market access, and compete effectively in a rapidly evolving global landscape.

Click the CONTACT US button to find out more.